As the Global and US Lead for Multiple Myeloma Patient Advocacy & Engagement at Takeda Oncology, Scott embodies the role of a true Patient Advocate – a trusted liaison between patient organizations and industry, as well as other stakeholders who shape the patient experience. From research & development to access and support services, Scott champions the voice of the patient at every step of the process of delivering potentially life-transforming therapies for patients with the greatest unmet needs. He uses real-world patient insights and patient experience data to design impactful education programs and help shape decisions in the industry. Scott also leads the US field-based team of Patient Advocacy Liaisons, a program aimed to uncover real, first-hand insights from the multiple myeloma community and create meaningful educational engagements for cancer patients and their loved ones. Scott is driven by enthusiasm, empathy, and urgency in his role as the Director of Patient Advocacy & Engagement at Takeda Oncology. He strives to be actively present with the multiple myeloma community, whether that is from the office, attending patient education programs, or by participating in advocacy events like the Moving Mountains for Multiple Myeloma hike to raise funds for cancer research. Scott has been recognized by the McGivney Global Advisors and The Lynx Group in being named “40 under 40 in Cancer” as well as in the PM360 ELITE Awards for his part in leading the Takeda Oncology Patient Leadership Council. His passion for helping patients is reflected in his own words: “Who’s not inspired by the opportunity to make a cancer diagnosis even the slightest bit better?”